Amrutajan Health Share Price

₹ 496.15

-₹0.50 (-0.1%)

Last updated 02 Nov, 2026, 15:29 IST

NSE: AMRUTANJAN

Amrutajan Health Share Price Today

As of 3 Nov 2026, Amrutajan Health share price is ₹496.15. The stock opened at ₹488.60, compared to its previous close of ₹496.65. During today's trading session, Amrutajan Health share price moved in the range of ₹488.60 to ₹499.05, with an average price of ₹493.83 for the day. Looking at its last 52-week, the stock has touched a low of ₹476.50 and a high of ₹744.00. On the performance front, Amrutajan Health share price has declined by 13.10% over the last six months and is down 31.45% on a year-on-year basis.

₹488.60

0.10% down today

₹499.05

1D LOW

1D HIGH

Amrutajan Health Stock Insights

Stock Performance

OutperformingBeat Nifty by 1.9 % in last 3 month

Shareholding Pattern

DIIDII decreased stake by 49.06%

Shareholding Pattern

FIIFII increased stake by 42.41%

Amrutajan Health Stock Insights

Stock Performance

OutperformingBeat Nifty by 1.9 % in last 3 month

Shareholding Pattern

DIIDII decreased stake by 49.06%

Shareholding Pattern

FIIFII increased stake by 42.41%

Amrutajan Health stock performance
Open	₹488.60
High	₹499.05
Low	₹488.60
Prev. close	₹496.65

Amrutajan Health trading activity
Volume	9,707
Average traded price	₹495.29
Last traded time	03:29:57 02 Nov
Last traded quantity	1

₹397.15₹595.65

Circuit Low

Circuit High

₹476.50₹744.00

52-Week Low

52-Week High

Circuit

₹397.15

₹595.65

52-week

₹476.50

₹744.00

Mkt Cap Cr

1,437.29

P/E

26.61

P/B

3.88

ROA

10.61%

ROE

17.42%

ROCE

23.31%

Quick Ratio

2.02

EV/EBITDA

17.65

Mkt Cap Cr

1,437.29

P/E

26.61

P/B

3.88

ROA

10.61%

ROE

17.42%

ROCE

23.31%

Quick Ratio

2.02

EV/EBITDA

17.65

Based on fundamentals, this stock's

Performance

Poor

Amrutanjan Healt has underperformed the market

Valuation

Overvalued

Amrutanjan Healt appears overvalued compared to its peers

Earnings

Neutral

Amrutanjan Healt earnings growth is positive

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Sun Pharmaceutical Industries	4,26,661.74	38.83	4.78	9.61%	13.79%	18.65%	2.31	22.27
Divis Laboratories	2,57,902.73	88.17	15.39	14.6%	15.32%	19.56%	3.5	58.97
Torrent Pharmaceuticals	1,74,402.47	83.09	9.49	4.7%	11.42%	11.37%	0.75	33.6
Laurus Labs	1,26,811.28	95.17	20.92	11.58%	22.11%	20.91%	0.68	54.77
Zydus Lifesciences	1,24,089.48	27.02	4.58	8.57%	18.59%	17.35%	0.91	16.42
Dr. Reddy's Laboratories	1,12,698.53	40.84	2.9	4.79%	7.21%	8.58%	1.35	19.05
Cipla	1,11,486.14	39.06	3.15	6.6%	8.18%	10.8%	2.5	21.03
Mankind Pharma	1,02,796.60	45.42	5.85	7.82%	12.76%	14.68%	0.74	25.01
Aurobindo Pharma	96,536.90	26.02	2.55	6.34%	9.25%	11.76%	1.15	12.38
Lupin	91,870.16	16.55	4.09	14.47%	23.76%	24.88%	1.42	9.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Amrutajan Health Company Background

ISIN

INE098F01031

Sector Market Cap

₹ 1,437.29 Cr

Amrutanjan Health Care Limited is an India-based company, which is engaged in the business of manufacturing, supplying and sale of products in pain management, congestion management, beverages, and hygiene and services in pain management. Its segments include OTC Products, Women Hygiene, Beverages and Others. The OTC Products segment is engaged in manufacturing products for pain management, congestion management and hygiene. The Women Hygiene includes Comfy Snug Fit, Comfy Snug Fit Extra Long, and Comfy Snug Fit Ultra XL. The Beverages segment is engaged in manufacturing fruit juices and oral hydration drinks. The Others segment includes the pain management center. The Company’s pain management products include Pain Balm Extra Power, Strong Pain Balm, New Maha Strong Pain Balm, Roll on and Advanced Back Pain + Roll-On, among others. Its congestion management products include Relief Cold Rub, Relief Nasal Inhaler, Relief Cough Syrup and Relief Swas Mint.

Amrutajan Health Financial Highlights

Revenue: Amrutajan Health reported revenue of ₹228.81 crore in FY17 vs ₹192.42 crore in FY16. It showed an increase of 18.91% on a yearly basis.
Operating Profit: Amrutajan Health reported an operating profit of ₹33.24 crore in FY17 vs ₹32.68 crore in FY16. It showed an increase of 1.71% on a year-on-year basis.
Net Profit: Amrutajan Health reported a net profit of ₹21.14 crore in FY17 vs ₹20.58 crore in FY16. It showed an increase of 2.72% on a yearly basis.

Amrutajan Health Quarterly Result Highlights

Amrutajan Health reported revenue of ₹106.78 crore in Jun 2026, compared with ₹154.50 crore in Mar 2026, representing a decrease of 30.89% on a quarter-on-quarter (QoQ) basis.
Amrutajan Health reported an operating profit of ₹6.07 crore in Jun 2026, compared with ₹21.02 crore in Mar 2026, representing a decrease of 71.12% on a quarter-on-quarter (QoQ) basis.
Amrutajan Health reported a profit of ₹4.37 crore in Jun 2026, compared with ₹16.19 crore in Mar 2026, reflecting a decrease of 73.01% on a QoQ basis.
The earnings per share (EPS) of Amrutajan Health stood at ₹20.03 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters

46.52%

FII

3.47%

Other DII

3.29%

Retail and other

43.11%

Mutual funds

3.60%

Foreign Institutional Investor (FII)

FII shareholding by period
Dec 2025	2.27%
Mar 2026	2.17%
Jun 2026	2.44%
Sep 2026	3.47%

Amrutajan Health Investment Returns

1 day

-0.05%

1 week

+1.36%

1 month

-3.27%

1 year

-31.45%

3 years

-17.44%

5 years

-46.25%

Amrutajan Health Share Price History

Amrutajan Health share price history by day, showing open and close prices and the percentage change
Day	Open / Close	Change %
02 Nov 26	₹488.60 / ₹496.40	-0.05%
30 Oct 26	₹488.30 / ₹496.65	+0.70%
29 Oct 26	₹490.10 / ₹493.20	+0.04%
28 Oct 26	₹492.70 / ₹493.00	+0.72%
27 Oct 26	₹495.00 / ₹489.50	-0.05%
26 Oct 26	₹487.65 / ₹489.75	+0.43%
23 Oct 26	₹493.00 / ₹487.65	-1.88%
22 Oct 26	₹498.95 / ₹497.00	+0.33%
21 Oct 26	₹504.90 / ₹495.35	-0.76%
19 Oct 26	₹516.95 / ₹499.15	-2.85%

Amrutajan Health Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Revenue	₹186.74	₹166.57	₹141.73	₹137.65
Other Income	₹5.68	₹4.48	₹2.94	₹4.27
Total Revenue	₹192.42	₹171.04	₹144.67	₹141.92
Total Expenses	₹159.74	₹146.90	₹125.29	₹126.44
Profit Before Tax	₹32.45	₹24.15	₹19.38	₹15.47
Tax	₹11.87	₹9.25	₹6.94	₹5.36
Profit After Tax	₹20.58	₹14.90	₹12.44	₹10.12
EPS - Basic	₹14.08	₹10.31	₹8.51	₹6.92
EPS - Diluted	₹14.08	₹10.31	₹8.51	₹6.92

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Profit before tax	₹32.68	₹24.15	₹19.38	₹15.47
Income before WC changes	₹31.38	₹24.48	₹22.89	₹18.53
Change in Assets	-₹5.47	-₹0.63	₹5.57	-₹6.30
Change in Liabilities	₹6.28	₹3.84	-₹3.66	₹1.92
Change in WC	₹0.81	₹3.22	₹1.91	-₹4.38
Cash flow from Operations	₹20.70	₹18.32	₹17.45	₹8.62
Cash flow from Investing	₹4.16	-₹4.89	₹16.49	₹7.73
Cash flow from Financing	-₹13.10	-₹11.93	-₹13.92	-₹14.26
Total Cash Flow	₹11.76	₹1.49	₹20.02	₹2.09
Cash (Start of the year)	₹30.67	₹29.17	₹9.15	₹7.06
Cash (End of the year)	₹42.42	₹30.67	₹29.17	₹14.91

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Non-Current Assets	₹39.95	₹41.06	₹42.02	₹60.78
Current Assets	₹100.49	₹82.84	₹78.25	₹63.38
Total Assets	₹140.44	₹123.90	₹120.27	₹124.16
Current Liabilities	₹27.98	₹25.85	₹27.25	₹37.99
Net Current Asset	₹72.52	₹56.98	₹51.00	₹25.39
Non-Current Liabilities	₹3.72	₹3.10	₹3.78	₹3.90
Equity Capital	₹108.74	₹94.95	₹89.24	₹82.27
Total Equity & Liabilities	₹140.44	₹123.90	₹120.27	₹124.16

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹502.55	₹451.82	₹421.23	₹379.64
Other Income	₹17.57	₹17.68	₹16.35	₹14.54
Total Revenue	₹520.13	₹469.50	₹437.58	₹394.18
Total Expenses	₹433.38	₹400.36	₹375.63	₹340.53
Profit Before Tax	₹77.89	₹69.13	₹61.95	₹53.65
Tax	₹19.97	₹18.30	₹16.97	₹13.81
Profit After Tax	₹57.92	₹50.83	₹44.97	₹39.83
EPS - Basic	₹20.03	₹17.58	₹15.50	₹13.63
EPS - Diluted	₹20.03	₹17.58	₹15.50	₹13.63

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹77.89	₹69.13	₹61.95	₹53.65
Income before WC changes	₹67.21	₹59.80	₹54.60	₹45.88
Change in Assets	-₹25.39	-₹7.41	-₹19.41	₹2.17
Change in Liabilities	₹13.17	₹16.43	₹9.23	-₹11.81
Change in WC	-₹12.21	₹9.02	-₹10.19	-₹9.64
Cash flow from Operations	₹35.97	₹50.90	₹27.91	₹20.18
Cash flow from Investing	-₹21.23	-₹30.97	₹19.17	-₹2.48
Cash flow from Financing	-₹13.62	-₹13.49	-₹48.27	-₹14.99
Total Cash Flow	₹1.12	₹6.44	-₹1.19	₹2.72
Cash (Start of the year)	₹10.16	₹3.71	₹4.90	₹2.19
Cash (End of the year)	₹11.27	₹10.16	₹3.71	₹4.90

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹217.24	₹130.72	₹71.19	₹102.15
Current Assets	₹291.65	₹290.67	₹295.68	₹259.95
Total Assets	₹508.89	₹421.39	₹366.87	₹362.09
Current Liabilities	₹126.18	₹84.58	₹69.92	₹63.01
Net Current Asset	₹165.46	₹206.09	₹225.76	₹196.94
Non-Current Liabilities	₹12.47	₹10.19	₹8.46	₹8.31
Equity Capital	₹370.23	₹326.61	₹288.49	₹290.77
Total Equity & Liabilities	₹508.89	₹421.39	₹366.87	₹362.09